Lingli Zhou

432 total citations
30 papers, 253 citations indexed

About

Lingli Zhou is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Lingli Zhou has authored 30 papers receiving a total of 253 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrinology, Diabetes and Metabolism, 12 papers in Molecular Biology and 9 papers in Surgery. Recurrent topics in Lingli Zhou's work include Diabetes Treatment and Management (12 papers), Diabetes Management and Research (8 papers) and Pancreatic function and diabetes (8 papers). Lingli Zhou is often cited by papers focused on Diabetes Treatment and Management (12 papers), Diabetes Management and Research (8 papers) and Pancreatic function and diabetes (8 papers). Lingli Zhou collaborates with scholars based in China. Lingli Zhou's co-authors include Xueyao Han, Xiaoling Cai, Wenjia Yang, Linong Ji, Simin Zhang, Linong Ji, Bo-Qiang Ma, Xianghai Zhou, Yifei Chen and Yingying Luo and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Lingli Zhou

29 papers receiving 249 citations

Peers

Lingli Zhou
Maki Takeuchi Japan
Kazuhiko Matsuzawa Japan
Miloš Stojanović Serbia
Jacek Kiljański United States
Eszter Berta Hungary
Jasna Klen Slovenia
Morten Schütt Germany
Fiona Carr United Kingdom
Miklós Bodor Hungary
Eugenia Morabito Italy
Maki Takeuchi Japan
Lingli Zhou
Citations per year, relative to Lingli Zhou Lingli Zhou (= 1×) peers Maki Takeuchi

Countries citing papers authored by Lingli Zhou

Since Specialization
Citations

This map shows the geographic impact of Lingli Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingli Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingli Zhou more than expected).

Fields of papers citing papers by Lingli Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingli Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingli Zhou. The network helps show where Lingli Zhou may publish in the future.

Co-authorship network of co-authors of Lingli Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Lingli Zhou. A scholar is included among the top collaborators of Lingli Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingli Zhou. Lingli Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Lingli, et al.. (2024). Barrier-free tomato fruit selection and location based on optimized semantic segmentation and obstacle perception algorithm. Frontiers in Plant Science. 15. 1460060–1460060. 1 indexed citations
2.
Gong, Siqian, Hong Lian, Yating Li, et al.. (2024). Exon Sequencing of HNF1β in Chinese Patients with Early-Onset Diabetes. Diabetes & Metabolism Journal. 49(2). 321–330.
3.
Zhang, Simin, Siqian Gong, Meng Li, et al.. (2024). Overburden of rare ALMS1 deleterious variants in Chinese early‐onset type 2 diabetes with severe insulin resistance. Diabetes/Metabolism Research and Reviews. 40(4). e3788–e3788. 3 indexed citations
4.
Zhou, Lingli, et al.. (2024). An Improved 2D Pose Estimation Algorithm for Extracting Phenotypic Parameters of Tomato Plants in Complex Backgrounds. Remote Sensing. 16(23). 4385–4385. 1 indexed citations
5.
Zou, Xiantong, Mengdie Hu, Lingli Zhou, et al.. (2023). Rare Variant in Metallothionein 1E Increases the Risk of Type 2 Diabetes in a Chinese Population. Diabetes Care. 46(12). 2249–2257. 3 indexed citations
6.
Liu, Tianqi, Xiuying Zhang, Long Li, et al.. (2022). Clinical evaluation of an automated TSI bridge immunoassay in the diagnosis of Graves’ disease and its relationship to the degree of hyperthyroidism. BMC Endocrine Disorders. 22(1). 218–218. 9 indexed citations
7.
Lv, Fang, Xiaoling Cai, Lingli Zhou, et al.. (2021). Sex-specific associations of serum insulin-like growth factor-1 with bone density and risk of fractures in Chinese patients with type 2 diabetes. Osteoporosis International. 32(6). 1165–1173. 8 indexed citations
8.
Zou, Xiantong, Xiaoling Cai, Wei Liu, et al.. (2021). Urinary C‐peptide/creatinine ratio: A useful biomarker of insulin resistance and refined classification of type 2 diabetes mellitus. Journal of Diabetes. 13(11). 893–904. 6 indexed citations
9.
10.
Luo, Yingying, Siqian Gong, Xianghai Zhou, et al.. (2020). Low-Frequency Genetic Variant in the Hepatic Glucokinase Gene Is Associated With Type 2 Diabetes and Insulin Resistance in Chinese Population. Diabetes. 70(3). 809–816. 3 indexed citations
11.
Gao, Ying, Xiaoling Cai, Ling Chen, et al.. (2019). Clinical Implications of Urinary C-Peptide Creatinine Ratio in Patients with Different Types of Diabetes. Journal of Diabetes Research. 2019. 1–8. 7 indexed citations
12.
Zhou, Lingli, Xiaoling Cai, Yingying Luo, Fang Zhang, & Linong Ji. (2019). Baseline Triglyceride Level Affected the Efficacy of Vildagliptin in Treating Type 2 Diabetes: A Post Hoc Analysis of the VISION Study. Journal of Diabetes Research. 2019. 1–5. 1 indexed citations
13.
Han, Xueyao, Xianghai Zhou, Yufeng Li, et al.. (2018). A new clinical screening strategy and prevalence estimation for glucokinase variant-induced diabetes in an adult Chinese population. Genetics in Medicine. 21(4). 939–947. 27 indexed citations
14.
Cai, Xiaoling, Liwei Ji, Yifei Chen, et al.. (2017). Comparisons of weight changes between sodium‐glucose cotransporter 2 inhibitors treatment and glucagon‐like peptide‐1 analogs treatment in type 2 diabetes patients: A meta‐analysis. Journal of Diabetes Investigation. 8(4). 510–517. 43 indexed citations
15.
Zhou, Lingli, Xiaoling Cai, Wenjia Yang, Xueyao Han, & Linong Ji. (2017). The Magnitude of Weight Loss Induced by Metformin is Independently Associated with BMI at Baseline in Newly Diagnosed Type 2 Diabetes: Post-hoc Analysis from Data of a Phase IV Open-labeled Trial. Advances in Clinical and Experimental Medicine. 26(4). 671–677. 4 indexed citations
16.
Gong, Siqian, Jiandong Guo, Xueyao Han, et al.. (2017). Clinical and Genetic Features of Patients With Type 2 Diabetes and Renal Glycosuria. The Journal of Clinical Endocrinology & Metabolism. 102(5). 1548–1556. 15 indexed citations
17.
Cai, Xiaoling, Wenjia Yang, Xueying Gao, et al.. (2016). Baseline Body Mass Index and the Efficacy of Hypoglycemic Treatment in Type 2 Diabetes: A Meta-Analysis. PLoS ONE. 11(12). e0166625–e0166625. 20 indexed citations
18.
Cai, Xiaoling, Xueying Gao, Wenjia Yang, et al.. (2016). DPP-4 Inhibitor Treatment in Chinese Type 2 Diabetes Patients: A Meta-Analysis. Diabetes Technology & Therapeutics. 18(12). 784–793. 10 indexed citations
19.
Zhou, Lingli, Xiaoling Cai, Minghui Li, Xueyao Han, & Linong Ji. (2016). Plasma NT-proBNP is independently associated with albuminuria in type 2 diabetes. Journal of Diabetes and its Complications. 30(4). 669–674. 6 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maki Takeuchi Breakdown of academic impact, for papers by Kazuhiko Matsuzawa Breakdown of academic impact, for papers by Miloš Stojanović Breakdown of academic impact, for papers by Jacek Kiljański Breakdown of academic impact, for papers by Eszter Berta Breakdown of academic impact, for papers by Jasna Klen Breakdown of academic impact, for papers by Morten Schütt Breakdown of academic impact, for papers by Fiona Carr Breakdown of academic impact, for papers by Miklós Bodor Breakdown of academic impact, for papers by Eugenia Morabito
Rankless by CCL
2026